Contrast Enhanced Ultrasound Market Size, Analysis, Trends, and Strategies 2024–2033

Overview and Scope

Contrast-enhanced ultrasound (CEUS) refers to a medical imaging technique that involves the use of contrast agents or microbubbles to enhance the visibility and clarity of ultrasound images. CEUS can be used to image blood perfusion in organs and measure blood flow rate in the heart and other organs.

Sizing and Forecast

The contrast enhanced ultrasound market size has grown strongly in recent years. It will grow from $1.93 billion in 2023 to $2.05 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to diagnostic accuracy and sensitivity, non-invasiveness and safety, rising incidence of liver diseases, global increase in aging population, growing preference for non-radiation techniques.

The contrast enhanced ultrasound market size is expected to see strong growth in the next few years. It will grow to $2.54 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise in cardiovascular diseases, increasing applications in pediatric imaging, expanding role in gastrointestinal imaging, growing focus on precision medicine, integration with artificial intelligence. Major trends in the forecast period include continued technological innovations, advancements in ultrasound technology, expanding applications in oncology, integration with multimodal imaging, real-time quantitative assessment, pediatric applications.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/contrast-enhanced-ultrasound-global-market-report

Segmentation & Regional Insights

The contrast enhanced ultrasound market covered in this report is segmented –

1) By Product: Equipment, Contrast Agent
2) By Technology: Non-targeted, Targeted
3) By Application: Hospitals, Clinics, Other Applications

North America was the largest region in the contrast-enhanced ultrasound market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contrast enhanced ultrasound market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13407&type=smp

Major Driver Impacting Market Growth

The rising prevalence of chronic diseases is expected to propel the growth of the contrast-enhanced ultrasound market going forward. Chronic diseases refer to long-term medical conditions that persist over an extended period and require ongoing medical management and care. Contrast-enhanced ultrasound helps provide real-time, detailed images of various chronic diseases, such as liver cirrhosis or vascular diseases associated with hypertension, contributing to more effective long-term management. For instance, in January 2023, according to a report published by the National Library of Medicine, a US-based agency, the number of individuals aged 50 years and older having one or more chronic illnesses is projected to rise by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Therefore, the rising prevalence of chronic diseases will drive the growth of the contrast-enhanced ultrasound market.

Key Industry Players

Major companies operating in the contrast enhanced ultrasound market report are General Electric Company, Bayer AG, Bristol-Myers Squibb Company, Siemens Healthcare GmbH, Koninklijke Philips N.V., Daiichi Sankyo Company Limited, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., J.B. Chemicals and Pharmaceuticals Ltd., Canon Medical Systems, Lantheus Medical Imaging Inc., Guerbet, Bracco Diagnostic Inc., Esaote S.p.A., Trivitron Healthcare Pvt. Ltd., BK Medical Holding Company Inc., Hitachi Healthcare, Chison Medical Technology Co. Ltd., SANOCHEMIA Pharmazeutika GmbH, SuperSonic Imagine SA, FUJIFILM Visualsonics Inc., Leriva Pharma SA, Samsung Healthcare, Jodas Expoim Pvt Ltd., nanoPET Pharma GmbH, Alpinion Medical Systems, Acusphere Inc., ContextVision AB, Teratech Corporation, Solstice Pharmaceuticals B.V.</b

The contrast enhanced ultrasound market report table of contents includes:

1. Executive Summary
2. Contrast Enhanced Ultrasound Market Characteristics
3. Contrast Enhanced Ultrasound Market Trends And Strategies
4. Contrast Enhanced Ultrasound Market – Macro Economic Scenario
5. Global Contrast Enhanced Ultrasound Market Size and Growth
.
.
.
32. Global Contrast Enhanced Ultrasound Market Competitive Benchmarking
33. Global Contrast Enhanced Ultrasound Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Contrast Enhanced Ultrasound Market
35. Contrast Enhanced Ultrasound Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model